<p>GC-MS peaks for the CRC patients and corresponding National Institute of Standards and Technology (NIST) targets for these peaks.</p
Results of multi-analysis of cytokines; comparisons between CRC patients and controls by multiple li...
<p>Crude incidence rates (per 1000 person-years) for categories of potential PNS in patients with NS...
Raw data of peak numbers and their corresponding areas from crude and processed samples obtained for...
<p>Analysis of Hs-CRP levels (ng/ml) in Coronary Artery Disease (CAD) patients, FDRS and Controls.</...
<p>Clinical characteristics of CRC patients and controls used for plasma and serum analysis.</p
<p>Patient and tumor characteristics of 86 cases of CRC stratified by MSI status.</p
<p><i>HR</i> hazard ratio, <i>CI</i> confidence interval, <i>P</i> values in bold were statistically...
<p>According to the optimal cut-off levels (2.86-fold), 72 patients with CRC were divided into two g...
<p>(A) Co-clustering matrix of CRC samples generated by NBS analysis. The matrix color intensity rep...
<p>A. Serum MIC-1 concentrations in GC patients (median = 1372 pg/ml) and controls (median = 351 p...
<p>Clinical characteristics of CRC patients according to levels of fecal RPS27L.</p
<p>Total and scaled NIHR CCRN core research funding and patients recruited to NIHR CRN portfolio stu...
<p>Clinical characteristics of CRC patients segregated by EMAST status, exclusive of MSI-H patients....
<p>The average accuracy of CRC for breast cancer dataset with reduced dimensionality.</p
<p>Univariate and multivariate Cox regression analysis for OS and DFS in CRC patients.</p
Results of multi-analysis of cytokines; comparisons between CRC patients and controls by multiple li...
<p>Crude incidence rates (per 1000 person-years) for categories of potential PNS in patients with NS...
Raw data of peak numbers and their corresponding areas from crude and processed samples obtained for...
<p>Analysis of Hs-CRP levels (ng/ml) in Coronary Artery Disease (CAD) patients, FDRS and Controls.</...
<p>Clinical characteristics of CRC patients and controls used for plasma and serum analysis.</p
<p>Patient and tumor characteristics of 86 cases of CRC stratified by MSI status.</p
<p><i>HR</i> hazard ratio, <i>CI</i> confidence interval, <i>P</i> values in bold were statistically...
<p>According to the optimal cut-off levels (2.86-fold), 72 patients with CRC were divided into two g...
<p>(A) Co-clustering matrix of CRC samples generated by NBS analysis. The matrix color intensity rep...
<p>A. Serum MIC-1 concentrations in GC patients (median = 1372 pg/ml) and controls (median = 351 p...
<p>Clinical characteristics of CRC patients according to levels of fecal RPS27L.</p
<p>Total and scaled NIHR CCRN core research funding and patients recruited to NIHR CRN portfolio stu...
<p>Clinical characteristics of CRC patients segregated by EMAST status, exclusive of MSI-H patients....
<p>The average accuracy of CRC for breast cancer dataset with reduced dimensionality.</p
<p>Univariate and multivariate Cox regression analysis for OS and DFS in CRC patients.</p
Results of multi-analysis of cytokines; comparisons between CRC patients and controls by multiple li...
<p>Crude incidence rates (per 1000 person-years) for categories of potential PNS in patients with NS...
Raw data of peak numbers and their corresponding areas from crude and processed samples obtained for...